MaxCyte, Inc. (MXCT) stock

MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3065% below fair value

$1.10−0.03 (-2.65%)

Close on Nov 11, 2026Market cap $113.53MP/E –Yield –

MaxCyte EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

MaxCyte's EPS for the twelve months ending Sep 30, 2026 was -$0.26. For fiscal 2025 it was -$0.42. The highest annual figure on record is -$0.17 in fiscal 2020.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.42	–
FY2024	Dec 31, 2024	-$0.39	–
FY2023	Dec 31, 2023	-$0.37	–
FY2022	Dec 31, 2022	-$0.23	–
FY2021	Dec 31, 2021	-$0.21	–
FY2020	Dec 31, 2020	-$0.17	–
FY2019	Dec 31, 2019	-$0.23	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.05	–
Q2 FY2026	Jun 30, 2026	-$0.08	–
Q1 FY2026	Mar 31, 2026	-$0.04	–
Q4 FY2025	Dec 31, 2025	-$0.09	–
Q3 FY2025	Sep 30, 2025	-$0.12	–
Q2 FY2025	Jun 30, 2025	-$0.12	–
Q1 FY2025	Mar 31, 2025	-$0.10	–
Q4 FY2024	Dec 31, 2024	-$0.10	–
Q3 FY2024	Sep 30, 2024	-$0.11	–
Q2 FY2024	Jun 30, 2024	-$0.09	–
Q1 FY2024	Mar 31, 2024	-$0.09	–
Q4 FY2023	Dec 31, 2023	-$0.05	–
Q3 FY2023	Sep 30, 2023	-$0.11	–
Q2 FY2023	Jun 30, 2023	-$0.10	–
Q1 FY2023	Mar 31, 2023	-$0.11	–
Q4 FY2022	Dec 31, 2022	-$0.05	–
Q3 FY2022	Sep 30, 2022	-$0.06	–
Q2 FY2022	Jun 30, 2022	-$0.08	–
Q1 FY2022	Mar 31, 2022	-$0.04	–
Q4 FY2021	Dec 31, 2021	-$0.05	–
Q3 FY2021	Sep 30, 2021	-$0.03	–
Q2 FY2021	Jun 30, 2021	-$0.05	–
Q1 FY2021	Mar 31, 2021	-$0.09	–
Q4 FY2020	Dec 31, 2020	-$0.03	–
Q3 FY2020	Sep 30, 2020	-$0.04	–
Q2 FY2020	Jun 30, 2020	-$0.05	–